
BDX · NYSE
Becton, Dickinson and Company
$198.91 -1.34 (-0.67%)
Company overview
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extension sets, closed-system drug transfer devices, hazardous drug detection devices, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NYSE
- Market cap
- $54.2B
- Employees
- 70,000
- Headquarters
- Franklin Lakes, NJ
- Website
- bd.com
- CEO
- Thomas E. Polen Jr.
- Listed
- February 21, 1973
- P/E
- 50.36
- Dividend yield
- 2.21%
Company financials
- Revenue
- $21.4B
- Gross profit
- $9.9B
- Operating income
- $2.3B
- EBITDA
- $4.2B
- Net income
- $1.1B
- EPS
- $3.95
- Total assets
- $50.8B
- Total debt
- $17.3B
- Gross margin
- 46.48%
- Net margin
- 5.33%
- Earnings yield
- 1.99%
Showing FY 2025